Toxic shock syndrome differential diagnosis: Difference between revisions
Usama Talib (talk | contribs) |
m Bot: Removing from Primary care |
||
(11 intermediate revisions by 6 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Toxic_shock_syndrome]] | |||
Line 15: | Line 15: | ||
*[[Steven johnson syndrome|Steven Johnson syndrome]] ([[SJS]]) | *[[Steven johnson syndrome|Steven Johnson syndrome]] ([[SJS]]) | ||
*[[Toxic epidermal necrolysis]] ([[TEN]]) | *[[Toxic epidermal necrolysis]] ([[TEN]]) | ||
*[[Scarlet fever]] | |||
*[[Red man syndrome]] | |||
*[[DRESS syndrome|Drug reaction with eosinophilia and systemic symptoms]] ([[DRESS syndrome]]) | |||
Clinical presentation of '''[[fever]]''' and '''[[rash]]''' must be differentiated from other diseases like: | Clinical presentation of '''[[fever]]''' and '''[[rash]]''' must be differentiated from other diseases like: | ||
* [[Viral exanthem]] | * [[Viral exanthem]] | ||
* [[Rickettsial disease]] | * [[Rickettsial disease]] | ||
Line 25: | Line 26: | ||
* [[Erythroderma|Exfoliative erythroderma syndrome]] | * [[Erythroderma|Exfoliative erythroderma syndrome]] | ||
* [[Erythema multiforme|Erythema multiforme major]] | * [[Erythema multiforme|Erythema multiforme major]] | ||
=== | === Differential Diagnoses in Patients with '''Fever, Hypotension and''' '''Rash'''=== | ||
{| class="wikitable" | {| class="wikitable" | ||
Line 34: | Line 34: | ||
! rowspan="2" style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Epidemiology}} | ! rowspan="2" style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Epidemiology}} | ||
! rowspan="2" style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Predisposing factors}} | ! rowspan="2" style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Predisposing factors}} | ||
! colspan="5" style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Clinical features}}<ref name="pmid3069202">{{cite journal |vauthors=Todd JK |title=Toxic shock syndrome |journal=Clin. Microbiol. Rev. |volume=1 |issue=4 |pages=432–46 |year=1988 |pmid=3069202 |pmc=358064 |doi= |url=}}</ref><ref name="pmid264839892">{{cite journal |vauthors=Kang JH |title=Febrile Illness with Skin Rashes |journal=Infect Chemother |volume=47 |issue=3 |pages=155–66 |year=2015 |pmid=26483989 |pmc=4607768 |doi=10.3947/ic.2015.47.3.155 |url=}}</ref><ref name="pmid12720556">{{cite journal |vauthors=Sivagnanam S, Deleu D |title=Red man syndrome |journal=Crit Care |volume=7 |issue=2 |pages=119–20 |year=2003 |pmid=12720556 |pmc=270616 |doi= |url=}}</ref> | ! colspan="5" style="width: 200px; background: #4479BA; text-align: center;" | {{fontcolor|#FFF|Clinical features}}<ref name="pmid3069202">{{cite journal |vauthors=Todd JK |title=Toxic shock syndrome |journal=Clin. Microbiol. Rev. |volume=1 |issue=4 |pages=432–46 |year=1988 |pmid=3069202 |pmc=358064 |doi= |url=}}</ref><ref name="pmid264839892">{{cite journal |vauthors=Kang JH |title=Febrile Illness with Skin Rashes |journal=Infect Chemother |volume=47 |issue=3 |pages=155–66 |year=2015 |pmid=26483989 |pmc=4607768 |doi=10.3947/ic.2015.47.3.155 |url=}}</ref><ref name="pmid12720556">{{cite journal |vauthors=Sivagnanam S, Deleu D |title=Red man syndrome |journal=Crit Care |volume=7 |issue=2 |pages=119–20 |year=2003 |pmid=12720556 |pmc=270616 |doi= |url=}}</ref> | ||
! rowspan="2" style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|'''Lab abnormalities'''}} | ! rowspan="2" style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|'''Lab abnormalities'''}} | ||
|- | |- | ||
Line 40: | Line 40: | ||
| style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|'''Symptoms'''}} | | style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|'''Symptoms'''}} | ||
|- | |- | ||
| rowspan="2" |Toxic shock syndrome | | rowspan="2" text-align: center;"|Toxic shock syndrome | ||
| rowspan="2" |Occurs in both adults and children (9:1 female predominance) | | rowspan="2" |Occurs in both adults and children (9:1 female predominance) | ||
| rowspan="2" | | | rowspan="2" text-align: center;"| | ||
* Occurs in association with [[vaginitis]] during [[menstruation]] following tampon use (S. aureus); | * Occurs in association with [[vaginitis]] during [[menstruation]] following tampon use (S. aureus); | ||
* As a complication of soft tissue infections ([[Streptococcus pyogenes|S. pyogenes]] or GAS) | * As a complication of soft tissue infections ([[Streptococcus pyogenes|S. pyogenes]] or GAS) | ||
* In females undergoing medical [[abortion]] | * In females undergoing medical [[abortion]] | ||
([[Clostridium sordellii|C. sordellii]]). | ([[Clostridium sordellii|C. sordellii]])<ref name="pmid2801850">{{cite journal |vauthors=McGregor JA, Soper DE, Lovell G, Todd JK |title=Maternal deaths associated with Clostridium sordellii infection |journal=Am. J. Obstet. Gynecol. |volume=161 |issue=4 |pages=987–95 |year=1989 |pmid=2801850 |doi= |url=}}</ref><ref name="pmid16049422">{{cite journal |vauthors= |title=Clostridium sordellii toxic shock syndrome after medical abortion with mifepristone and intravaginal misoprostol--United States and Canada, 2001-2005 |journal=MMWR Morb. Mortal. Wkly. Rep. |volume=54 |issue=29 |pages=724 |year=2005 |pmid=16049422 |doi= |url=}}</ref><ref name="pmid16319384">{{cite journal |vauthors=Fischer M, Bhatnagar J, Guarner J, Reagan S, Hacker JK, Van Meter SH, Poukens V, Whiteman DB, Iton A, Cheung M, Dassey DE, Shieh WJ, Zaki SR |title=Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion |journal=N. Engl. J. Med. |volume=353 |issue=22 |pages=2352–60 |year=2005 |pmid=16319384 |doi=10.1056/NEJMoa051620 |url=}}</ref><ref name="pmid12439811">{{cite journal |vauthors=Sinave C, Le Templier G, Blouin D, Léveillé F, Deland E |title=Toxic shock syndrome due to Clostridium sordellii: a dramatic postpartum and postabortion disease |journal=Clin. Infect. Dis. |volume=35 |issue=11 |pages=1441–3 |year=2002 |pmid=12439811 |doi=10.1086/344464 |url=}}</ref><ref name="pmid19628200">{{cite journal |vauthors=Ho CS, Bhatnagar J, Cohen AL, Hacker JK, Zane SB, Reagan S, Fischer M, Shieh WJ, Guarner J, Ahmad S, Zaki SR, McDonald LC |title=Undiagnosed cases of fatal Clostridium-associated toxic shock in Californian women of childbearing age |journal=Am. J. Obstet. Gynecol. |volume=201 |issue=5 |pages=459.e1–7 |year=2009 |pmid=19628200 |doi=10.1016/j.ajog.2009.05.023 |url=}}</ref> | ||
|'''[[Fever]]''' | | text-align: center;"| '''[[Fever]]''' | ||
|'''[[Hypotension]]''' | | text-align: center;"| '''[[Hypotension]]''' | ||
|'''Diffuse [[Rash]]''' | | text-align: center;"| '''Diffuse [[Rash]]''' | ||
|'''Other signs''' | | text-align: center;" | '''Other signs''' | ||
| rowspan="2" | | | rowspan="2" text-align: center;"| | ||
* Diarrhea | * Diarrhea | ||
* Vomiting | * Vomiting | ||
Line 64: | Line 64: | ||
* [[Pyuria]] of [[renal]] origin.<ref name="pmid7282746">{{cite journal |vauthors=Chesney RW, Chesney PJ, Davis JP, Segar WE |title=Renal manifestations of the staphylococcal toxic-shock syndrome |journal=Am. J. Med. |volume=71 |issue=4 |pages=583–8 |year=1981 |pmid=7282746 |doi= |url=}}</ref> | * [[Pyuria]] of [[renal]] origin.<ref name="pmid7282746">{{cite journal |vauthors=Chesney RW, Chesney PJ, Davis JP, Segar WE |title=Renal manifestations of the staphylococcal toxic-shock syndrome |journal=Am. J. Med. |volume=71 |issue=4 |pages=583–8 |year=1981 |pmid=7282746 |doi= |url=}}</ref> | ||
|- | |- | ||
| | | + | ||
| | | + | ||
| | | + | ||
| | | | ||
* Nonpitting systemic [[edema]] | * Nonpitting systemic [[edema]] | ||
Line 78: | Line 78: | ||
* Close contact with a carrier | * Close contact with a carrier | ||
* Intimate kissing and cigarette smoking are associated with increased risk of meningococcal carriage<ref name="pmid16707051">{{cite journal |vauthors=MacLennan J, Kafatos G, Neal K, Andrews N, Cameron JC, Roberts R, Evans MR, Cann K, Baxter DN, Maiden MC, Stuart JM |title=Social behavior and meningococcal carriage in British teenagers |journal=Emerging Infect. Dis. |volume=12 |issue=6 |pages=950–7 |year=2006 |pmid=16707051 |pmc=3373034 |doi= |url=}}</ref> | * Intimate kissing and cigarette smoking are associated with increased risk of meningococcal carriage<ref name="pmid16707051">{{cite journal |vauthors=MacLennan J, Kafatos G, Neal K, Andrews N, Cameron JC, Roberts R, Evans MR, Cann K, Baxter DN, Maiden MC, Stuart JM |title=Social behavior and meningococcal carriage in British teenagers |journal=Emerging Infect. Dis. |volume=12 |issue=6 |pages=950–7 |year=2006 |pmid=16707051 |pmc=3373034 |doi= |url=}}</ref> | ||
| | | + | ||
| | | + | ||
| | | + | ||
| | | | ||
* Positive [[Kernig's sign]] | * Positive [[Kernig's sign]] | ||
* Positive [[Brudzinski's sign]]<ref name="pmid14779273">{{cite journal |vauthors=WARTENBERG R |title=The signs of Brudzinski and of Kernig |journal=J. Pediatr. |volume=37 |issue=4 |pages=679–84 |year=1950 |pmid=14779273 |doi= |url=}}</ref> | * Positive [[Brudzinski's sign]]<ref name="pmid14779273">{{cite journal |vauthors=WARTENBERG R |title=The signs of Brudzinski and of Kernig |journal=J. Pediatr. |volume=37 |issue=4 |pages=679–84 |year=1950 |pmid=14779273 |doi= |url=}}</ref> | ||
* [[Photophobia]]<ref name="pmid25470712">{{cite journal |vauthors=Bush LM |title=Case 28-2014: A man with a rash, headache, fever, nausea, and photophobia |journal=N. Engl. J. Med. |volume=371 |issue=23 |pages=2238–9 |year=2014 |pmid=25470712 |doi=10.1056/NEJMc1412237#SA2 |url=}}</ref> | * [[Photophobia]]<ref name="pmid25470712">{{cite journal |vauthors=Bush LM |title=Case 28-2014: A man with a rash, headache, fever, nausea, and photophobia |journal=N. Engl. J. Med. |volume=371 |issue=23 |pages=2238–9 |year=2014 |pmid=25470712 |doi=10.1056/NEJMc1412237#SA2 |url=}}</ref> | ||
| | | | ||
* [[Vomiting]] | * [[Vomiting]] | ||
Line 92: | Line 91: | ||
* Cool extremities | * Cool extremities | ||
* [[Seizure|Seizures]] | * [[Seizure|Seizures]] | ||
* Rash: [[petechiae]] and [[purpura]] ('''star-shaped rash, which can develop into purple bruising. [[Meningococcal]] rash can usually be confirmed by a glass test in which the rash does not fade away under pressure'''.<ref name="urlMeningitis Symptoms - Meningitis Research Foundation" /> | * Rash: [[petechiae]] and [[purpura]] ('''star-shaped rash, which can develop into purple bruising. [[Meningococcal]] rash can usually be confirmed by a glass test in which the rash does not fade away under pressure'''.<ref name="urlMeningitis Symptoms - Meningitis Research Foundation">{{cite web |url=http://www.meningitis.org/symptoms |title=Meningitis Symptoms - Meningitis Research Foundation |format= |work= |accessdate=}}</ref> | ||
| | | | ||
* Positive blood cultures ([[Neisseria meningitidis]]) | * Positive blood cultures ([[Neisseria meningitidis]]) | ||
Line 103: | Line 102: | ||
** CSF gram stain and culture may be positive | ** CSF gram stain and culture may be positive | ||
|- | |- | ||
| | |[[Stevens-Johnson syndrome|Stevens Johnson syndrome]] ([[Stevens-Johnson syndrome|SJS]]) | ||
|[[HLA-B]]*1502 [[gene]] leads to increased susceptibility<ref name="pmid15057820">{{cite journal |vauthors=Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT |title=Medical genetics: a marker for Stevens-Johnson syndrome |journal=Nature |volume=428 |issue=6982 |pages=486 |year=2004 |pmid=15057820 |doi=10.1038/428486a |url=}}</ref> | |[[HLA-B]]*1502 [[gene]] leads to increased susceptibility<ref name="pmid15057820">{{cite journal |vauthors=Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT |title=Medical genetics: a marker for Stevens-Johnson syndrome |journal=Nature |volume=428 |issue=6982 |pages=486 |year=2004 |pmid=15057820 |doi=10.1038/428486a |url=}}</ref> | ||
|Triggered by certain medications, most commonly: | |Triggered by certain medications, most commonly: | ||
Line 112: | Line 111: | ||
* [[Mycoplasma pneumoniae]] | * [[Mycoplasma pneumoniae]] | ||
* [[Herpes simplex virus]]<ref name="pmid211627212">{{cite journal |vauthors=Harr T, French LE |title=Toxic epidermal necrolysis and Stevens-Johnson syndrome |journal=Orphanet J Rare Dis |volume=5 |issue= |pages=39 |year=2010 |pmid=21162721 |pmc=3018455 |doi=10.1186/1750-1172-5-39 |url=}}</ref> | * [[Herpes simplex virus]]<ref name="pmid211627212">{{cite journal |vauthors=Harr T, French LE |title=Toxic epidermal necrolysis and Stevens-Johnson syndrome |journal=Orphanet J Rare Dis |volume=5 |issue= |pages=39 |year=2010 |pmid=21162721 |pmc=3018455 |doi=10.1186/1750-1172-5-39 |url=}}</ref> | ||
| | | + | ||
| | | + | ||
| | | + | ||
| | | | ||
* Positive Nikolsky sign (exerting mechanical pressure on several [[erythematous]] zones resluts in peeling of skin) | * Positive Nikolsky sign (exerting mechanical pressure on several [[erythematous]] zones resluts in peeling of skin) | ||
Line 131: | Line 130: | ||
* Histological work up of skin sections reveal wide spread [[Necrosis|necrotic]] [[Epidermis (skin)|epidermis]] involving all layers | * Histological work up of skin sections reveal wide spread [[Necrosis|necrotic]] [[Epidermis (skin)|epidermis]] involving all layers | ||
|- | |- | ||
|Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome | |[[DRESS syndrome|Drug Reaction with Eosinophilia and Systemic Symptoms]] ([[DRESS syndrome|DRESS]]) Syndrome | ||
| | | | ||
| | | | ||
Line 141: | Line 140: | ||
* [[Nevirapine]] | * [[Nevirapine]] | ||
* [[Clindamycin]] | * [[Clindamycin]] | ||
| | | + | ||
| | | + | ||
| | | + | ||
| | | | ||
* Multi-organ dysfunction:<ref name="pmid19153346">{{cite journal |vauthors=Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, Chosidow O, Guillot I, Paradis V, Joly P, Crickx B, Ranger-Rogez S, Descamps V |title=Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure |journal=Arch Dermatol |volume=145 |issue=1 |pages=67–72 |year=2009 |pmid=19153346 |doi=10.1001/archderm.145.1.67 |url=}}</ref> | * Multi-organ dysfunction:<ref name="pmid19153346">{{cite journal |vauthors=Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, Chosidow O, Guillot I, Paradis V, Joly P, Crickx B, Ranger-Rogez S, Descamps V |title=Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure |journal=Arch Dermatol |volume=145 |issue=1 |pages=67–72 |year=2009 |pmid=19153346 |doi=10.1001/archderm.145.1.67 |url=}}</ref> | ||
Line 162: | Line 161: | ||
* Increased [[ALT]] and [[Aspartate transaminase|AST]]<ref name="pmid191533462">{{cite journal |vauthors=Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, Chosidow O, Guillot I, Paradis V, Joly P, Crickx B, Ranger-Rogez S, Descamps V |title=Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure |journal=Arch Dermatol |volume=145 |issue=1 |pages=67–72 |year=2009 |pmid=19153346 |doi=10.1001/archderm.145.1.67 |url=}}</ref> | * Increased [[ALT]] and [[Aspartate transaminase|AST]]<ref name="pmid191533462">{{cite journal |vauthors=Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, Chosidow O, Guillot I, Paradis V, Joly P, Crickx B, Ranger-Rogez S, Descamps V |title=Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure |journal=Arch Dermatol |volume=145 |issue=1 |pages=67–72 |year=2009 |pmid=19153346 |doi=10.1001/archderm.145.1.67 |url=}}</ref> | ||
|- | |- | ||
| | |[[Red man syndrome]] | ||
|Patients in whom | |Patients in whom the offending drug infusion is given over less than 1 hour and who are not pre-treated with [[diphenhydramine]]<ref name="pmid1955716">{{cite journal |vauthors=Wallace MR, Mascola JR, Oldfield EC |title=Red man syndrome: incidence, etiology, and prophylaxis |journal=J. Infect. Dis. |volume=164 |issue=6 |pages=1180–5 |year=1991 |pmid=1955716 |doi= |url=}}</ref> | ||
|Hypersensitivity to: | |Hypersensitivity to:<ref name="pmid127205562">{{cite journal |vauthors=Sivagnanam S, Deleu D |title=Red man syndrome |journal=Crit Care |volume=7 |issue=2 |pages=119–20 |year=2003 |pmid=12720556 |pmc=270616 |doi= |url=}}</ref> | ||
* [[Vancomycin]] | * [[Vancomycin]] | ||
* [[Ciprofloxacin]] | * [[Ciprofloxacin]] | ||
Line 170: | Line 169: | ||
* [[Rifampin|Rifampicin]] | * [[Rifampin|Rifampicin]] | ||
* [[Teicoplanin]] | * [[Teicoplanin]] | ||
| | * [[Cefepime]] | ||
| | | + | ||
| | | + | ||
| + | |||
| | | | ||
* Local infusion site [[erythema]] | |||
* [[Angioedema]] (rare) | |||
| | | | ||
* Headache | * Headache | ||
Line 193: | Line 195: | ||
* Infection in combination with [[genetic predisposition]] to an [[autoimmune]] mechanism | * Infection in combination with [[genetic predisposition]] to an [[autoimmune]] mechanism | ||
([[Vasculitis|autoimmune vasculitis]]) | ([[Vasculitis|autoimmune vasculitis]]) | ||
| | | + | ||
| | | + | ||
| | | + | ||
| | | | ||
* Non-[[suppurative]], painless bilateral conjunctival [[inflammation]] ([[conjunctivitis]]) | * Non-[[suppurative]], painless bilateral conjunctival [[inflammation]] ([[conjunctivitis]]) | ||
Line 216: | Line 218: | ||
|Distributed equally among both genders. Most commonly affects children between five and fifteen years of age. | |Distributed equally among both genders. Most commonly affects children between five and fifteen years of age. | ||
|Occurs after streptococcal [[pharyngitis]]/[[tonsillitis]] | |Occurs after streptococcal [[pharyngitis]]/[[tonsillitis]] | ||
| | | + | ||
| | |<nowiki>+/-</nowiki> | ||
| | | + | ||
| | | | ||
* Pastia's sign (puncta and skin crease accentuation of the [[erythema]]) | * Pastia's sign (puncta and skin crease accentuation of the [[erythema]]) | ||
Line 232: | Line 234: | ||
* Antihyaluronidase, and antifibrinolysin may be positive. | * Antihyaluronidase, and antifibrinolysin may be positive. | ||
|} | |} | ||
=== | ===Common Differential Diagnoses in Patients with Fever and Rash=== | ||
{| class="wikitable" | {| class="wikitable" | ||
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Disease}} | ! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Disease}} | ||
Line 246: | Line 247: | ||
| | | | ||
* The insect injects [[formic acid]], which can cause an immediate [[skin]] reaction often resulting in a [[rash|'''rash''']] '''and swelling in the injured area, often with formation of [[vesicles]].''' | * The insect injects [[formic acid]], which can cause an immediate [[skin]] reaction often resulting in a [[rash|'''rash''']] '''and swelling in the injured area, often with formation of [[vesicles]].''' | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px;"|[[Measles]] | | style="background: #DCDCDC; padding: 5px;"|[[Measles]] | ||
Line 313: | Line 310: | ||
| | | | ||
* The [[symptoms]] may include [[maculopapular rash|'''maculopapular rash''']], [[petechial rash]], [[abdominal pain]] and [[joint pain]]. | * The [[symptoms]] may include [[maculopapular rash|'''maculopapular rash''']], [[petechial rash]], [[abdominal pain]] and [[joint pain]]. | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px;"|[[Varicella-zoster virus]] | | style="background: #DCDCDC; padding: 5px;"|[[Varicella-zoster virus]] | ||
Line 325: | Line 318: | ||
| | | | ||
* It commonly starts with [[conjunctival]] and catarrhal [[symptoms]] and then '''characteristic spots appearing in two or three waves, mainly on the body and head, rather than the hands, becoming itchy raw pox (small open sores which heal mostly without scarring).''' Touching the fluid from a [[chickenpox]] blister can also spread the disease. | * It commonly starts with [[conjunctival]] and catarrhal [[symptoms]] and then '''characteristic spots appearing in two or three waves, mainly on the body and head, rather than the hands, becoming itchy raw pox (small open sores which heal mostly without scarring).''' Touching the fluid from a [[chickenpox]] blister can also spread the disease. | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px;"|[[Rickettsialpox|Rickettsial pox]] | | style="background: #DCDCDC; padding: 5px;"|[[Rickettsialpox|Rickettsial pox]] | ||
Line 347: | Line 336: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Syndromes]] | [[Category:Syndromes]] | ||
[[Category:Needs overview]] | |||
[[Category:Needs content]] | |||
[[Category:Emergency mdicine]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
Latest revision as of 00:26, 30 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
Toxic shock syndrome (TSS) may have a similar presentation to some diseases which present as a rash, fever and hypotension. Some features are unique to toxic shock syndrome and can be used to differentiate it from other diseases.
Differentiating Toxic Shock Syndrome from other Diseases
Toxic shock syndrome requires all 3 manifestations of fever, hypotension and diffuse scarlatiniform rash (innumerable small red papules that are diffusely distributed plus erythema, which blanches and desquamates one or two weeks after onset of illness). It presents with various signs of infection, hemodynamic dysfunction and organ failure.
Clinical presentation of fever, hypotension and rash must be differentiated from other diseases like:
- Meningococcemia
- Steven Johnson syndrome (SJS)
- Toxic epidermal necrolysis (TEN)
- Scarlet fever
- Red man syndrome
- Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome)
Clinical presentation of fever and rash must be differentiated from other diseases like:
- Viral exanthem
- Rickettsial disease
- Kawasaki disease
- Staphylococcal scalded skin syndrome
- Exfoliative erythroderma syndrome
- Erythema multiforme major
Differential Diagnoses in Patients with Fever, Hypotension and Rash
Disease | Epidemiology | Predisposing factors | Clinical features[1][2][3] | Lab abnormalities | ||||
---|---|---|---|---|---|---|---|---|
Signs | Symptoms | |||||||
Toxic shock syndrome | Occurs in both adults and children (9:1 female predominance) |
|
Fever | Hypotension | Diffuse Rash | Other signs |
|
|
+ | + | + |
| |||||
Meningococcemia | Occurs in young adults living in close proximity (college dorms, military recruits)[13] |
|
+ | + | + |
|
| |
Stevens Johnson syndrome (SJS) | HLA-B*1502 gene leads to increased susceptibility[18] | Triggered by certain medications, most commonly: | + | + | + |
|
| |
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome | + | + | + |
|
|
| ||
Red man syndrome | Patients in whom the offending drug infusion is given over less than 1 hour and who are not pre-treated with diphenhydramine[28] | Hypersensitivity to:[29] | + | + | + |
|
|
No elevation in tryptase levels indicating that it is an anaphylactoid reaction[30] |
Kawasaki | Occurs in children, usually age 1-4 years |
|
+ | + | + |
|
|
|
Scarlet fever | Distributed equally among both genders. Most commonly affects children between five and fifteen years of age. | Occurs after streptococcal pharyngitis/tonsillitis | + | +/- | + |
|
Rash:
|
|
Common Differential Diagnoses in Patients with Fever and Rash
Disease | Features |
---|---|
Impetigo | |
Insect bites |
|
Measles |
|
Monkeypox |
|
Rubella |
|
Atypical measles |
|
Coxsackievirus |
|
Acne |
|
Syphilis | It commonly presents with gneralized systemic symptoms such as malaise, fatigue, headache and fever. Skin eruptions may be subtle and asymptomatic It is classically described as:
|
Molluscum contagiosum |
|
Mononucleosis |
|
Toxic erythema | |
Rat-bite fever | |
Parvovirus B19 | |
Cytomegalovirus |
|
Scarlet fever |
|
Rocky Mountain spotted fever |
|
Varicella-zoster virus | |
Chickenpox |
|
Rickettsial pox | |
Meningitis |
|
References
- ↑ Todd JK (1988). "Toxic shock syndrome". Clin. Microbiol. Rev. 1 (4): 432–46. PMC 358064. PMID 3069202.
- ↑ Kang JH (2015). "Febrile Illness with Skin Rashes". Infect Chemother. 47 (3): 155–66. doi:10.3947/ic.2015.47.3.155. PMC 4607768. PMID 26483989.
- ↑ Sivagnanam S, Deleu D (2003). "Red man syndrome". Crit Care. 7 (2): 119–20. PMC 270616. PMID 12720556.
- ↑ McGregor JA, Soper DE, Lovell G, Todd JK (1989). "Maternal deaths associated with Clostridium sordellii infection". Am. J. Obstet. Gynecol. 161 (4): 987–95. PMID 2801850.
- ↑ "Clostridium sordellii toxic shock syndrome after medical abortion with mifepristone and intravaginal misoprostol--United States and Canada, 2001-2005". MMWR Morb. Mortal. Wkly. Rep. 54 (29): 724. 2005. PMID 16049422.
- ↑ Fischer M, Bhatnagar J, Guarner J, Reagan S, Hacker JK, Van Meter SH, Poukens V, Whiteman DB, Iton A, Cheung M, Dassey DE, Shieh WJ, Zaki SR (2005). "Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion". N. Engl. J. Med. 353 (22): 2352–60. doi:10.1056/NEJMoa051620. PMID 16319384.
- ↑ Sinave C, Le Templier G, Blouin D, Léveillé F, Deland E (2002). "Toxic shock syndrome due to Clostridium sordellii: a dramatic postpartum and postabortion disease". Clin. Infect. Dis. 35 (11): 1441–3. doi:10.1086/344464. PMID 12439811.
- ↑ Ho CS, Bhatnagar J, Cohen AL, Hacker JK, Zane SB, Reagan S, Fischer M, Shieh WJ, Guarner J, Ahmad S, Zaki SR, McDonald LC (2009). "Undiagnosed cases of fatal Clostridium-associated toxic shock in Californian women of childbearing age". Am. J. Obstet. Gynecol. 201 (5): 459.e1–7. doi:10.1016/j.ajog.2009.05.023. PMID 19628200.
- ↑ Kang JH (2015). "Febrile Illness with Skin Rashes". Infect Chemother. 47 (3): 155–66. doi:10.3947/ic.2015.47.3.155. PMC 4607768. PMID 26483989.
- ↑ Brook MG, Bannister BA (1988). "Scarlet fever can mimic toxic shock syndrome". Postgrad Med J. 64 (758): 965–7. PMC 2429080. PMID 3256819.
- ↑ Minemura M, Tajiri K, Shimizu Y (2014). "Liver involvement in systemic infection". World J Hepatol. 6 (9): 632–42. doi:10.4254/wjh.v6.i9.632. PMC 4179142. PMID 25276279.
- ↑ Chesney RW, Chesney PJ, Davis JP, Segar WE (1981). "Renal manifestations of the staphylococcal toxic-shock syndrome". Am. J. Med. 71 (4): 583–8. PMID 7282746.
- ↑ Harrison LH (2010). "Epidemiological profile of meningococcal disease in the United States". Clin. Infect. Dis. 50 Suppl 2: S37–44. doi:10.1086/648963. PMC 2820831. PMID 20144015.
- ↑ MacLennan J, Kafatos G, Neal K, Andrews N, Cameron JC, Roberts R, Evans MR, Cann K, Baxter DN, Maiden MC, Stuart JM (2006). "Social behavior and meningococcal carriage in British teenagers". Emerging Infect. Dis. 12 (6): 950–7. PMC 3373034. PMID 16707051.
- ↑ WARTENBERG R (1950). "The signs of Brudzinski and of Kernig". J. Pediatr. 37 (4): 679–84. PMID 14779273.
- ↑ Bush LM (2014). "Case 28-2014: A man with a rash, headache, fever, nausea, and photophobia". N. Engl. J. Med. 371 (23): 2238–9. doi:10.1056/NEJMc1412237#SA2. PMID 25470712.
- ↑ "Meningitis Symptoms - Meningitis Research Foundation".
- ↑ Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT (2004). "Medical genetics: a marker for Stevens-Johnson syndrome". Nature. 428 (6982): 486. doi:10.1038/428486a. PMID 15057820.
- ↑ Techasatian L, Panombualert S, Uppala R, Jetsrisuparb C (2016). "Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital". World J Pediatr. doi:10.1007/s12519-016-0057-3. PMID 27650525.
- ↑ Harr T, French LE (2010). "Toxic epidermal necrolysis and Stevens-Johnson syndrome". Orphanet J Rare Dis. 5: 39. doi:10.1186/1750-1172-5-39. PMC 3018455. PMID 21162721.
- ↑ Harr T, French LE (2010). "Toxic epidermal necrolysis and Stevens-Johnson syndrome". Orphanet J Rare Dis. 5: 39. doi:10.1186/1750-1172-5-39. PMC 3018455. PMID 21162721.
- ↑ Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM (2007). "Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management". Cornea. 26 (2): 123–9. doi:10.1097/ICO.0b013e31802eb264. PMID 17251797.
- ↑ Harr T, French LE (2010). "Toxic epidermal necrolysis and Stevens-Johnson syndrome". Orphanet J Rare Dis. 5: 39. doi:10.1186/1750-1172-5-39. PMC 3018455. PMID 21162721.
- ↑ Choudhary S, McLeod M, Torchia D, Romanelli P (2013). "Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome". J Clin Aesthet Dermatol. 6 (6): 31–7. PMC 3718748. PMID 23882307.
- ↑ Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, Chosidow O, Guillot I, Paradis V, Joly P, Crickx B, Ranger-Rogez S, Descamps V (2009). "Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure". Arch Dermatol. 145 (1): 67–72. doi:10.1001/archderm.145.1.67. PMID 19153346.
- ↑ Peyrière H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, Hillaire-Buys D (2006). "Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?". Br. J. Dermatol. 155 (2): 422–8. doi:10.1111/j.1365-2133.2006.07284.x. PMID 16882184.
- ↑ Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, Chosidow O, Guillot I, Paradis V, Joly P, Crickx B, Ranger-Rogez S, Descamps V (2009). "Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure". Arch Dermatol. 145 (1): 67–72. doi:10.1001/archderm.145.1.67. PMID 19153346.
- ↑ Wallace MR, Mascola JR, Oldfield EC (1991). "Red man syndrome: incidence, etiology, and prophylaxis". J. Infect. Dis. 164 (6): 1180–5. PMID 1955716.
- ↑ Sivagnanam S, Deleu D (2003). "Red man syndrome". Crit Care. 7 (2): 119–20. PMC 270616. PMID 12720556.
- ↑ Renz CL, Laroche D, Thurn JD, Finn HA, Lynch JP, Thisted R, Moss J (1998). "Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions". Anesthesiology. 89 (3): 620–5. PMID 9743397.
- ↑ Lin YJ, Cheng MC, Lo MH, Chien SJ (2015). "Early Differentiation of Kawasaki Disease Shock Syndrome and Toxic Shock Syndrome in a Pediatric Intensive Care Unit". Pediatr. Infect. Dis. J. 34 (11): 1163–7. doi:10.1097/INF.0000000000000852. PMID 26222065.